On August 20, 2013, Dean Cai of Shenzhen Second People's Hospital visited the company and inspected it. The company’s chief scientist Professor Liu Yong and the company’s CEO Mr. Sun personally received them and introduced the company’s technical products and development goals.

         Dean Cai spoke highly of the company's technology, and said that the institute is interested in advanced international technologies. At the same time, President Cai suggested that hospitals and companies conduct in-depth and extensive discussions on the feasibility of clinical applications on the basis of scientific research cooperation. I hope to find a development path that integrates production, learning, and research, and make unremitting efforts for the scientific research and clinical treatment of tumor biotherapy in Shenzhen to catch up with developed countries.